India to examine purported irregularities during drug regulator

<p>US health advisers urged regulators to approve Truvada, done by Gilead Sciences, as a initial surety tablet opposite HIV/AIDS instead of only a diagnosis for putrescent people.</p>
<p><img src="http://imageads.googleadservices.com/pagead/ads?format=468x30_aff_img&client=&channel=&output=png&cuid=2125&url=%20http%3A%2F%2Fmedicalinfo.info%2F%3Fp%3D2125" alt="ads?format=468x30_aff_img&client=&channe" /></p>...